22nd January
We were absolutely delighted to be featured in S&P Global last week in an article written by Joseph Harvey. See the article covering this exciting business update below.
Posts about Reverse Study:
TriviumVet launch The REVERSE CKD Study recruiting cats with Chronic Kidney Disease (CKD)
7th February
We at TriviumVet received great excitement at this year's Feline Veterinary Medicine Association (formerly AAFP) conference on the work we have been doing in the area of CKD. We...
TriviumVet's Feline Chronic Kidney Disease (CKD) candidate deemed eligible for the Expanded Conditional Approval Pathway by the FDA!
10th October
FDA’s Centre for Veterinary Medicine deems TriviumVet’s feline Chronic Kidney Disease (CKD) therapeutic candidate eligible for the Expanded Conditional Approval pathway
Spotlight Series - The "REVERSE" Feline Chronic Kidney Disease Study at The Ohio State University Veterinary School
17th November
Spotlight on REVERSE The first post in our Spotlight Series where we shine a light on one of our Clinical Trials or Projects. One of our most exciting projects at TriviumVet is...
TriviumVet work with The Ohio State University evaluating the benefit of Rapamycin in cats.
15th April
We are delighted to be working with The Ohio State University on an exciting clinical trial evaluating the benefit a new drug in cats with chronic kidney disease. Details of the...
TriviumVet's Feline Chronic Kidney Disease (CKD) candidate deemed eligible for the Expanded Conditional Approval Pathway by the FDA!
10th October
FDA’s Centre for Veterinary Medicine deems TriviumVet’s feline Chronic Kidney Disease (CKD) therapeutic candidate eligible for the Expanded Conditional Approval pathway
Spotlight Series - The "REVERSE" Feline Chronic Kidney Disease Study at The Ohio State University Veterinary School
17th November
Spotlight on REVERSE The first post in our Spotlight Series where we shine a light on one of our Clinical Trials or Projects. One of our most exciting projects at TriviumVet is...
TriviumVet work with The Ohio State University evaluating the benefit of Rapamycin in cats.
15th April
We are delighted to be working with The Ohio State University on an exciting clinical trial evaluating the benefit a new drug in cats with chronic kidney disease. Details of the...